Atlas Trials

Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease

Clinical trial NCT04394117 · COMPLETED

Trial details

NCT number
NCT04394117
Sponsor
The George Institute
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Coronavirus Disease 2019COVID-19
Start date
2020-06-19
Primary completion
2021-11-14
Enrollment
787

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.